Brain cancer vaccine complete successful phase 1 trials
Diffuse gliomas are a type of brain cancer that is especially difficult to treat, but 70 percent of low-grade gliomas have a single gene mutation that affects an isocitrate dehydrogenase 1 (IDH1) enzyme. This is what allowed German Cancer Research Center scientist Michael Platten to create a Read More...